CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
This Quarter Return
+6.46%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$92.1M
AUM Growth
+$92.1M
(+14%)
Cap. Flow
+$5.21M
Cap. Flow
% of AUM
5.66%
Top 10 Holdings %
Top 10 Hldgs %
95.14%
Holding
26
New
6
Increased
10
Reduced
6
Closed
1
Top Buys
| 1 |
SCYNEXIS
SCYX
|
$6.53M |
| 2 |
Investcorp Credit Management BDC
ICMB
|
$6.06M |
| 3 |
PG&E
PCG
|
$988K |
| 4 |
GARS
Garrison Capital Inc.
GARS
|
$934K |
| 5 |
U-Haul Holding Co
UHAL
|
$932K |
Top Sells
| 1 |
KALA BIO
KALA
|
$10.1M |
| 2 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$1.22M |
| 3 |
ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
|
$239K |
| 4 |
Adient
ADNT
|
$53.6K |
| 5 |
Indaptus Therapeutics
INDP
|
$52.2K |
Sector Composition
| 1 | Healthcare | 69.65% |
| 2 | Financials | 10.36% |
| 3 | Real Estate | 1.51% |
| 4 | Utilities | 1.07% |
| 5 | Industrials | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SBBP
1
DELISTED
Strongbridge Biopharma plc.
SBBP
| $47.3M | 51.34% | 5,376,039 -138,955 | -3% | -$1.22M |
|
|
GARS
2
DELISTED
Garrison Capital Inc.
GARS
| $9.05M | 9.83% | 1,115,072 +115,072 | +12% | +$934K |
|
|
MTEM
3
DELISTED
Molecular Templates, Inc.
MTEM
| $8.31M | 9.02% | 1,038,787 +25,000 | +2% | +$200K |
|
|
4
Investcorp Credit Management BDC
ICMB
$42.6M
| $6.64M | 7.21% | 809,772 +739,370 | +1,050% | +$6.06M |
|
|
5
SCYNEXIS
SCYX
$34.9M
| $6.53M | 7.08% | +4,870,409 | New | +$6.53M |
|
|
AGRX
6
DELISTED
Agile Therapeutics, Inc
AGRX
| $4.66M | 5.06% | 1,814,949 -5,063 | -0.3% | -$13K |
|
7
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.86M | 2.02% | 9,312 +367 | +4% | +$73.2K |
|
|
JBGS
8
JBG SMITH
JBGS
$1.32B
| $1.39M | 1.51% | 41,170 | – | – |
|
|
9
PG&E
PCG
$33.6B
| $988K | 1.07% | +22,500 | New | +$988K |
|
|
10
U-Haul Holding Co
UHAL
$10.8B
| $932K | 1.01% | +2,700 | New | +$932K |
|
|
ONCT
11
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $877K | 0.95% | 49,393 -13,476 | -21% | -$239K |
|
12
Barings BDC
BBDC
$1.04B
| $543K | 0.59% | 48,831 +8,251 | +20% | +$91.8K |
|
13
FS KKR Capital
FSK
$5.11B
| $508K | 0.55% | 70,115 +39,409 | +128% | +$286K |
|
14
AB InBev
BUD
$122B
| $486K | 0.53% | +4,425 | New | +$486K |
|
|
ABDC
15
DELISTED
Alcentra Capital Corp
ABDC
| $446K | 0.48% | 64,136 +4,574 | +8% | +$31.8K |
|
|
16
Indaptus Therapeutics
INDP
$7.19M
| $395K | 0.43% | 64,280 -8,502 | -12% | -$52.2K |
|
17
Aclaris Therapeutics
ACRS
$209M
| $370K | 0.4% | 21,142 +3,148 | +17% | +$55.1K |
|
18
Madrigal Pharmaceuticals
MDGL
$9.76B
| $233K | 0.25% | 1,999 -419 | -17% | -$48.8K |
|
|
19
Adient
ADNT
$2.01B
| $229K | 0.25% | 3,838 -899 | -19% | -$53.6K |
|
|
DRNA
20
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $125K | 0.14% | +13,074 | New | +$125K |
|
|
MRNS
21
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $102K | 0.11% | 26,827 +8,184 | +44% | +$31.1K |
|
22
Catalyst Pharmaceutical
CPRX
$2.52B
| $86K | 0.09% | 36,079 +2,969 | +9% | +$7.08K |
|
|
SRRA
23
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $78K | 0.08% | +37,582 | New | +$78K |
|
24
iShares Russell 2000 ETF
IWM
$67B
| – | – | 0 | – | – |
|
|
25
KALA BIO
KALA
$78.8M
| – | – | -544,220 | Closed | -$10.1M |
|